A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blastsGuillermo Garcia‐Manero, Oliver G. Ottmann, Miklós Egyed et al.|Leukemia|2017Cited by 70